Keywords: اریتروپویتین; Erythropoietin; Bone marrow-derived mesenchymal stem cells; Migration; Acute kidney injury; Hypoxia/re-oxygenation;
مقالات ISI اریتروپویتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اریتروپویتین; Training; Myokine; Erythropoietin; CTACK; TRAIL;
Keywords: اریتروپویتین; Liver cirrhosis; Erythropoietin; Surgical resection; Protective effect; Liver regeneration;
Keywords: اریتروپویتین; Performance enhancing drugs; Doping; Anabolic steroids; Erythropoietin; Sports; Drug policy;
Keywords: اریتروپویتین; BMI; body mass index; eGFR; estimated glomerular filtration rate; EPO; erythropoietin; hs-CRP; high-sensitivity C-reactive protein; IQR; interquartile range; MCV; mean corpuscular volume;
Keywords: اریتروپویتین; Hydrophilic interaction liquid chromatography; Mass spectrometry; Intact glycoproteins; Interferon-βâ¯ââ¯1a; Erythropoietin;
Keywords: اریتروپویتین; Critical illness; Erythropoietin; Lymphotoxin alpha;
Keywords: اریتروپویتین; EPO; erythropoietin; fEPSP; field excitatory post synaptic potential; DMOG; dimethyloxalylglycine; HIF; hypoxia inducible factor; PHD; prolyl hydroxylase domain; VEGF; vascular endothelial growth factor; Prolyl hydroxylase inhibition; Hypoxia; Hippocampus
Keywords: اریتروپویتین; Extractables; Leachables; Trimellitates; Rubber stopper; Elastomeric closures; Human immunoglobulin; Erythropoietin; Protein aggregation; Polysorbates;
Keywords: اریتروپویتین; Ang-1; Angiopoietin1; Ang-2; Angiopoietin-2; BDNF; Brain-Derived Neurotrophic Factor; bFGF; basic Fibroblast Growth Factor; CRP; C-Reactive Protein; DAS-II; Differential Ability Scales-II; EPO; Erythropoietin; ICAM-1; Intercellular Adhesion Molecule â
Keywords: اریتروپویتین; Aml; amlodipine; Ca2+; free calcium; DHP; dihydropyridine; Dil; diltiazem; Epo; erythropoietin; EpoR; erythropoietin receptor; FBS; fetal bovine serum; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; PBS; phosphate-buffered saline; Pyr3; TRPC3 inhibitor;
Keywords: اریتروپویتین; acute kidney injury; bone; erythropoietin; FGF23; sepsis;
Keywords: اریتروپویتین; bid; twice daily; CNHSQ; Children's National Health System Questionnaire; EPO; erythropoietin; FeSo4; ferrous sulfate 300 mg tid; IM; intramuscular; IV; intravenous; LAR; long-acting release; NA; not available; OD; once daily; OHQ; Orthostatic Hypotension
Keywords: اریتروپویتین; CC3; cleaved cysteine-aspartic protease 3; EPO; erythropoietin; HC; hippocampus; HI; hypoxic-ischemic; HIF; hypoxia-inducible transcription factor; PHI; prolyl-4-hydroxylase inhibitor; SVZ; subventricular zone; VEGF; vascular endothelial growth factor; VT
Keywords: اریتروپویتین; spinal cord; ischemic reperfusion injury; thoracoabdominal aortic aneurysm; AKT; serine/threonine-specific kinase; BCL-2; B cell lymphoma 2; βcR; beta common receptor; BMS; Basso Mouse Scale; CREB; adenosine 3â²,5â²-cyclic monophosphate response elemen
Keywords: اریتروپویتین; Erythropoietin; Type 2 diabetes; Diabetic nephropathy; Zebrafish;
Keywords: اریتروپویتین; ADAM; a disintegrin and metalloproteinase; AGT; angiotensinogen gene; AMD; age-related macular degeneration; ANG; angiopoietin; BDNF; brain-derived neutrotrophic factor; BW; birth weight; DR; diabetic retinopathy; eNOS; endothelial nitric oxide synthase;
Keywords: اریتروپویتین; 3Ã-HSD; 3Ã-hydroxysteroid dehydrogenase-isomerase; ABPM; ambulatory blood pressure monitoring; Ang II; angiotensin II; ARB; angiotensin receptor blocker; AT1; angiotensin receptor type 1; AT2; angiotensin receptor type 2; ACE; angiotensin-converting enz
Keywords: اریتروپویتین; AGE; Advanced glycation end-product; AR; Aldose reductase; ACR; Albumin/creatinine ratio; CTGF; Connective tissue growth factor; DM; Diabetes mellitus; DAG; Diacylglycerol; DN; Diabetic nephropathy; DR; Diabetic retinopathy; DCM; Diabetic cardiomyopathy;
Keywords: اریتروپویتین; AMD; age-related macular degeneration; ARPE; arising retinal pigment epithelial cells; b-FGF; basic fibroblast growth factor; BSA; bovine serum albumin; BDNF; brain-derived neurotrophic factor; CNS; Central Nervous System; CNTF; ciliary neurotrophic facto
Keywords: اریتروپویتین; Erythropoietin; Erythropoietin receptor; Neuroprotection; Oxidative stress;
Keywords: اریتروپویتین; Sodium-glucose cotransporter-2 (SGLT2) inhibitors; Type 2 diabetes; Diabetic kidney disease (DKD); Ketosis; Erythropoietin; Glucagon like peptide-1 (GLP-1);
Keywords: اریتروپویتین; Anemia; Erythropoietin; Chronic kidney disease; Cancer; Safety; Effectiveness; Cost-effectiveness; Systematic review;
Keywords: اریتروپویتین; Erythropoietin; Doping detection; Athlete biological passport; Biomarkers; Omics technologies;
Keywords: اریتروپویتین; ACD; anemia of chronic diseases; AD; Alzheimer's disease; AI; anemia of inflammation; AS; arterial stiffness; AUC; area under the curve; AUCROC; the area under the receiver operating characteristic curve; CAD-; coronary artery disease; CD; Crhon's dis
Keywords: اریتروپویتین; BOLD; Blood Oxygen Level Dependent; CA IX; Carbonic anhydrase 9; ECG; Electrocardiography; EPO; Erythropoietin; EPR; Electron paramagnetic resonance; HIF; Hypoxia-inducible Factor; IHD; Ischaemic heart disease; IR; Infrared; LOX; Lysyl oxidase; MOBILE; Ma
Keywords: اریتروپویتین; AI; anaemia of inflammation; ARE; anti-oxidant responsive element; ATP; adenosine triphosphate; Bmp; bone morphogenetic protein; CD; cluster of differentiation; C/EBP; CCAAT enhancer-binding protein; CO; carbon monoxide; CREB; cyclic adenosine monophospha
Keywords: اریتروپویتین; Erythropoietin; Repackaging; Polypropylene; EPO; Pharmacopeia;
Keywords: اریتروپویتین; ALP; Alkaline phosphatase; BFR; bone formation rate; BSP; Bone sialoprotein; BV/TV; bone volume/total volume, trabecular bone fraction; CTX; carboxy-terminal collagen crosslinks; Conn.D; connectivity density; rHuEPO; Erythropoietin (EPO)/recombinant human
Keywords: اریتروپویتین; Chronic kidney disease; Chronic inflammation; Cytokines; Erythropoietin; Chronic disease anemia;
Keywords: اریتروپویتین; Hypoxia; Hypoxia-inducible factor; Prolyl-4-hydroxylase; Erythropoietin; Chronic kidney disease;
Keywords: اریتروپویتین; Akt; protein kinase B; ATP; adenosine triphosphate; CK-MB; creatine kinase; EPO; erythropoietin; I/R; ischemia/reperfusion; IPC; ischemic preconditioning; IPOC; ischemic postconditioning; LDH; lactate dehydrogenase; LY294002; PI-3K inhibitor; mito KATP; m
Keywords: اریتروپویتین; BPD; Bronchopulmonary dysplasia; CP; Cerebral palsy; EPO; Erythropoietin; IVH; Intraventricular hemorrhage; NICU; Neonatal intensive care; OI; Oxygen index; OUH; Oulu University Hospital; PDA; Patent ductus arteriosus; PVL; Periventricular leukomalacia; R
Keywords: اریتروپویتین; erythropoietin; darbepoetin; cognitive development; very low birth weight; neurodevelopmental outcome; Darbe; Darbepoetin alfa; Epo; Erythropoietin; ESA; Erythropoiesis-stimulating agents; BASC-2; Behavioral Assessment System of Children - Second Editio
Keywords: اریتروپویتین; anemia; erythropoietin; hypoxia-inducible factor; prolyl hydroxylase domain;
Keywords: اریتروپویتین; mIL-11; interleukin-11 mutein; PEG-mIL-11; PEGylated mIL-11; mPEG-SC; methoxy polyethylene glycol succinimidyl carbonate; AUC; area-under-the curve; Cmax; maximum plasma concentration; G-CSF; , granulocyte colony stimulating factor; EPO; erythropoietin; I
Keywords: اریتروپویتین; Erythropoietin; Anemia; Hypoxia; Progesterone; Mifepristone; Estrus cycle;
Keywords: اریتروپویتین; Anemia; Ancianos; Deficiencias nutricionales; Eritropoyetina; Inflamación; Anemia indeterminada; Anaemia; Elderly; Nutritional deficiencies; Erythropoietin; Inflammation; Indeterminate anaemia;
Keywords: اریتروپویتین; AA; arachidonic acid; AF; amniotic fluid; BPD; bronchopulmonary dysplasia; CAT; catalase; CS; cesarean section; DHA; docosahexanoic acid; DR; delivery room; EPO; erythropoietin; FiO2; oxygen inspiratory fraction 0.21-1.0); GC-MS/MS; gas chromatography c
Keywords: اریتروپویتین; BBB; blood brain barrier; CNS; central nervous system; CSF; cerebrospinal fluid; EPO; erythropoietin; MO; micro organ; TARGT; transduced autologous restorative gene therapy; Blood brain barrier; Targeted delivery; Central nervous system; Brain; Gene thera
Keywords: اریتروپویتین; EPO; erythropoietin; IL3; interleukin; NKA; Na+,K+-ATPase; PMCA; plasma membrane Ca++-ATPase; SCF; stem cell factor; Sed-tub; tubulin in sedimentable fraction of erythrocytes; TEM; transmission electron microscopy; Tubulin; Erythrocyte; Sedimentable fract
Keywords: اریتروپویتین; WMD; White matter damage;; HI; hypoxic-ischemia;; EPO; erythropoietin;; BCAO; bilateral carotid artery occlusion;; MBP; myelin basic protein;; MWM; Morris water-maze;; PVL; periventricular leukomalacia;; HE; hematoxylin-eosin;; IHC; Immunohistochemistry;;
Keywords: اریتروپویتین; Anaemia; Elderly; Nutritional deficiencies; Erythropoietin; Inflammation; Indeterminate anaemia; Anemia; Ancianos; Deficiencias nutricionales; Eritropoyetina; Inflamación; Anemia indeterminada;
Keywords: اریتروپویتین; BM; bone marrow; CAR cells; CXCL12-abundant reticular cells; DTX; diphtheria toxin; EMP; erythroblast macrophage protein; EMR; EGF-like module containing mucin-like hormone receptor; EPO; erythropoietin; G-CSF; granulocyte colony stimulating factor; HSC;
Keywords: اریتروپویتین; %O2; percent oxygen level; Akt; Protein kinase B; CD34; Hematopoietic progenitor cell antigen; EPO; erythropoietin; EPO-R; EPO receptor; Hb; hemoglobin; HIF; hypoxia-inducible factor; NADPH; nicotinamide adenine dinucleotide phosphate; NO; nitric oxide; N
Keywords: اریتروپویتین; erythropoietin; meta-analysis; retinopathy of prematurity;
Keywords: اریتروپویتین; βcR; beta common receptor; cEpo; carbamylated erythropoietin; eNOS; endothelial nitric oxide synthase; Epo; erythropoietin; EpoR; erythropoietin receptor; FBS; fetal bovine serum; NAC; N acetyl-cysteine; L-NMMA; NG-methyl-l-arginine acetate; NO; nitric o
Liquid chromatography - high resolution mass spectrometry-based metabolomic approach for the detection of Continuous Erythropoiesis Receptor Activator effects in horse doping control
Keywords: اریتروپویتین; Metabolomics; Biofluids; Horse; LC-HRMS; Erythropoietin; Doping control;
Keywords: اریتروپویتین; CNS; central nervous system; EPO; erythropoietin; ERK; extracellular signal-regulated kinase; GFAP; glial fibrillary acadic protein; HIF-1alpha; hypoxia-inducible factor-1 alpha; IP; ischmia-preconditionning; IPcNCM; ischemia-preconditioned neuron culture
Keywords: اریتروپویتین; Artesunate; Erythropoietin; Cerebral malaria; Outcome;